BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
| 07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -16.44% | -305.95% | -241.46% | -299.15% | 64.66% |
| Total Depreciation and Amortization | -- | -- | 185.02% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 3.45% | -- | -- |
| Total Other Non-Cash Items | 100.00% | -750.00% | -1,670.00% | 646.25% | -- |
| Change in Net Operating Assets | -6.19% | 72.39% | 132.41% | 51.97% | -10.52% |
| Cash from Operations | 100.00% | 100.00% | 98.04% | 93.55% | -60,600.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | 100.00% | 0.00% | 66.67% | -600.00% |
